ProfileGDS5822 / ILMN_2669912
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 92% 88% 92% 90% 94% 85% 91% 90% 93% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1638.292
GSM1276600PDAC Late Ablation Control 2403.488
GSM1276601PDAC Late Ablation Control 378092
GSM1276602PDAC Late Ablation 1448.690
GSM1276603PDAC Late Ablation 21057.794
GSM1276604PDAC Late Ablation 327685
GSM1303940PDAC Late Ablation_anti-CTLA4 1582.291
GSM1303941PDAC Late Ablation_anti-CTLA4 2596.690
GSM1303942PDAC Late Ablation_anti-CTLA4 3904.193